Balyasny Asset Management’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,740
Closed -$387K 2876
2025
Q4
$387K Sell
17,740
-75,536
-81% -$1.57M ﹤0.01% 2635
2025
Q3
$2M Hold
93,276
﹤0.01% 1789
2025
Q2
$2.39M Buy
93,276
+16,279
+21% +$476K ﹤0.01% 1647
2025
Q1
$2.82M Buy
76,997
+23,843
+45% +$820K ﹤0.01% 1531
2024
Q4
$1.63M Sell
53,154
-7,928
-13% -$264K ﹤0.01% 1752
2024
Q3
$2.3M Buy
61,082
+52,431
+606% +$2.02M ﹤0.01% 1612
2024
Q2
$342K Buy
+8,651
New +$280K ﹤0.01% 2192

Other funds holding ATEX

Balyasny Asset Management's ATEX Position: Q1 2026 in Review

Balyasny Asset Management sold out of Anterix (ATEX) in Q1 2026, closing a stake of 17,740 shares — an estimated $387K sold.

Balyasny Asset Management first reported a position in ATEX in Q2 2024 and held it in 7 quarters. The position peaked at $2.82M in Q1 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Balyasny Asset Management reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
  • Balyasny Asset Management sold 17,740 Anterix shares in Q1 2026, an estimated $387K.
  • Balyasny Asset Management first reported a position in Anterix in Q2 2024 and held it in 7 quarters.
  • Balyasny Asset Management's Anterix position peaked at $2.82M in Q1 2025.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.